|
High $5.29 |
Low $5.12 |
Trades 1,945 |
Turnover $3,576,754 |
Volume 686,116 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (14-Nov) $794,931,520 (489th) |
Close (30-Jun) $5.19 |
Volume (30-Jun) 686,116 |
Shortsold (9-Nov) 31,690 (0.05%) (500th) |
|
52w High $5.17 |
52w Low $1.00 |
P/E 9.97 |
EPS -0.34 |
[ARTICLE] This medtech says a $7.8b opportunity can reverse its image problem
A news article has been posted about AVITA Medical, Inc on the AFR. The article was published around , on 7 December 2022 at 10:20am.
The new CEO of spray-on skin company Avita Medical says there is a “pot of gold” on the horizon for the biotech company, but he knows investors will take some convincing.
Read ArticleAVH was $1.94 at the close of trade on 06 December 2022
| Recent Articles about ASX:AVH | |
|---|---|
| 3-Nov | Appendix 3G - Notification of issue, conversion or payment up ... - AFR
company-announcements.afr.com |
| 3-Nov | AVITA MEDICAL, INC. (ASX:AVH) Cleansing Notice under section ...
company-announcements.afr.com |
| 27-Oct | Notification of cessation of securities Appendix 3H - AFR
company-announcements.afr.com |
| 27-Oct | INVESTMENT UPDATE AND NTA REPORT SEPTEMBER 2026 - AFR
company-announcements.afr.com |
| 20-Oct | 20 October 2026 Company Announcements Australian Securities ...
company-announcements.afr.com |
| 20-Oct | AVITA Medical to Announce Third Quarter 2026 Financial Results
company-announcements.afr.com |
| 5-Oct | Appendix 3G - Notification of issue, conversion or payment up ... - AFR
company-announcements.afr.com |
| 4-Oct | AVITA Medical PermeaDerm I Clinical Study Readout - AFR
company-announcements.afr.com |
| 24-Sep | Annual Report 2026 - AFR
company-announcements.afr.com |
| 23-Sep | Notification of cessation of securities Appendix 3H - AFR
company-announcements.afr.com |
| Tracked |
Find all articles about AVITA Medical, Inc, including others on the AFR, on the media page.
If you were already registered, log in here.